eric topol glp 1 The list of conditions for which GLP-1 drugs provide benefit independent of weight loss keeps growing. Add psoriatic arthritis #AAD26 @AADskin A Big Week for GLP-1

In these cases, the factors driving a patients weight may not respond strongly to this type of treatment

Other GLP-1 drugs like Wegovy and Zepbound were developed and tested specifically for obesity treatment with higher doses optimized for weight management outcomes

Victims and families deserve accountability, and the legal system provides a path to pursue compensation for medical costs, lost income, and the immense personal toll of these injuries

Md 51, 15841592

Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: a systematic review and meta-analysis of randomized controlled trials

Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, Diaconescu G, Yim HJ, Heo J, Janczewska E, Wong A, Idriz N, Imamura M, Rizzardini G, Takaguchi K, Andreone P, Arbune M, Hou J, Park SJ, Vata A, Cremer J, Elston R, Luki T, Quinn G, Maynard L, Kendrick S, Plein H, Campbell F, Paff M, Theodore D, B-Clear Study Group